Responses
Immunotherapy biomarkers
Original research
T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinoma
Compose a Response to This Article
Other responses
No responses have been published for this article.
